John Paul II Hospital

Running trials

• Enrolling by invitation

  A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients

  NCT06445673· Source

• Recruiting

  Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

  NCT06584266· Source

• Active, not recruiting

  TrEatment Approach in the Multimodal Era Registry

  NCT05629052· Source

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Source

• Active, not recruiting

  Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)

  NCT05279651· Phase 3· Source

• Active, not recruiting

  COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events

  NCT05333068· Source

• Recruiting

  Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEt-covered CGUARD (SAFEGUARD-STROKE)

  NCT05195658· Source

• Recruiting

  TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure

  NCT05250349· Source

• Active, not recruiting

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

  NCT07218029· Phase 3· Source

• Recruiting

  Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Patients

  NCT04973579· Source

• Enrolling by invitation

  Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)

  NCT04545112· Source

• Active, not recruiting

  A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

  NCT04025879· Phase 3· Source

• Recruiting

  DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL

  NCT03959748· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure3 recruiting
• Stroke3 recruiting
• Coronary artery disease2 recruiting
• High blood pressure2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Amyloidosis1 recruiting
• Atrial fibrillation1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Active, not recruiting

  A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

  NCT04819100· Phase 3· Source

• Terminated

  Levosimendan In Ambulatory Heart Failure Patients

  NCT04705337· Phase 4· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Source

• Terminated

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· Phase 3· Source

• Completed

  Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)

  NCT03829332· Phase 3· Source

• Completed

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· Phase 3· Source

• Completed

  Cryo Global Registry

  NCT02752737· Source

• Completed

  A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation

  NCT02444338· Source

• Completed

  Drug-coated Balloon in de Novo Chronic Total Occlusions

  NCT05977842· Source

• Completed

  ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)

  NCT01757665· Source

Trial sites

• 6160051 - Krakowski Szpital Specjalistyczny im. Jana Pawła II1 trial
• Department of Cardiac and Vascular Diseases, John Paul II Hospital3 trials
• Department of Cardiac and Vascular Diseases, The John Paul II Hospital1 trial
• Jagiellonian University; John Paul II Hospital1 trial
• John Paul II Hospital3 trials
• Krakowski Szpital Specjalistyczny im. Jana Pawla II3 trials
• Krakowski Szpital Specjalistyczny im. Jana Pawla II, Oddział Kliniczny Chorób Serca i Naczyń z Pododdziałem Intensywnego Nadzoru Kardiologicznego, Pradnicka 800 trials
• Krakowski Szpital Specjalistyczny im Jana Pawla II (Site 0253)1 trial
• Krakowski Szpital Specjalistyczny im. Jana Pawla II (Site 1756)0 trials
• Krakowski Szpital Specjalistyczny im Jana Pawla II (Site 2420)0 trials
• Krakowski Szpital Specjalistyczny im. Jana Pawła II (Site 2614)0 trials
• Krakowski Szpital Specjalistyczny im Jana Pawla II (Site 2801)1 trial
• The John Paul II Hosp.,Dept.of Coronary Heart Disease,Krakow1 trial
• Krakowski Szpital Specjalistyczny im. Jana Pawła II6 trials
• John Paul II Hospital Krakow2 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Pulmonary arterial hypertension16 works · 5 trials